See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI103.64▲ 4.19%
← BAKKA page
XStocksXray
Market X-Ray report · 22 October 2026

P/f Bakkafrost (BAKKA)

Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026

Key indicators

Last closeNOK 459.20
52-week range390.80 – 526.00
Return, 1 month / 3 months+5.7% / +3.3%
Return, 1 year / 3 years−3.5% / +3.5%
TrendUptrend
RSI (14)61
Volatility (1 year)29.3%
Worst drawdown (1 year)-23.3%
Average daily value traded46.33M NOK
Dividend yield1.6%

Market X-Ray price-based

61/ 100 · High confidence · ahead of 66% of stocks on this exchange
Trend61
Momentum54
Stability (higher is calmer)66
Liquidity88
Income32

Five-year price chart navy: price · brown: 200-day average

3624575526477422021-102023-012024-042025-072026-10

About the company

P/f Bakkafrost is a salmon farming company based in the Faroe Islands. It breeds, farms, harvests and processes Atlantic salmon, and it also makes fish feed for its own operations and for other farmers. The company sells fresh and frozen salmon products to customers in export markets around the world, and it runs hatcheries, sea sites and processing plants across the islands.

The shares are listed on the Oslo Stock Exchange in Norway under the code BAKKA, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

P/f Bakkafrost (BAKKA) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 459.20 on 22 October 2026.

Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 101 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 3.5% and over the last three months it rose 3.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
P/f Bakkafrost (BAKKA)

The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange

Lens and metricValueScoreReading
Trend61 · FairMixed trend against its averages.
Above 200-day average2.8%
From 52-week high-11.9%
Momentum54 · FairTypical recent returns for this exchange.
3-month return3.3%
6-month return4.1%
12-month return, skipping the last month-8.7%
Stability (higher is calmer)66 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)29.3%
Worst drawdown, 1 year (smaller is calmer)-23.3%
Liquidity88 · StrongTrades actively.
Average daily value traded46.33M NOK
Zero-volume days0.0%
Income32 · WeakDividend is small or irregular.
Dividend yield1.6%
Years with dividends5

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Income: Dividend is small or irregular.

Returns

1 week+4.2%
1 month+5.7%
3 months+3.3%
6 months+4.1%
1 year−3.5%
3 years+3.5%
5 years−35.0%

Signals

50-day / 200-day average450.90 / 446.48
Golden / death cross (60 days)Golden, 29 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)9.97

Technical summary

DailyStrongly bullish12 bullish · 1 neutral · 3 bearish
WeeklyBullish7 bullish · 1 neutral · 4 bearish
MonthlyNeutral3 bullish · 1 neutral · 4 bearish

Recent dividends

Ex-dividend dateAmount per share
4 May 2026DKK 5.0564
2 May 2025DKK 13.3735
2 May 2024DKK 13.6879
2 May 2023DKK 15.6274
2 May 2022DKK 6.7032
12 Apr 2021DKK 4.9600

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026